activation of dormant parasites in the liver. Primaquine PO for 14 days (0.25 to 0.5 mg/kg once daily in children â‰¥ 15 kg; 15 mg once daily in adults) can be given to eliminate these parasites, after the initial treatment with CQ or an ACT. However, this treatment is only recommended for patients living in areas where reinfection is unlikely, i.e. non-endemic, low transmission areas or in countries aiming for elimination of malaria. This treatment is contra-indicated in individuals with G6PD deficiency. If G6PD deficiency cannot be tested individually, the decision to prescribe primaquine must take into account the prevalence of deficiency in the population. Treatment of uncomplicated falciparum malaria Antimalarial treatment During pregnancy, see Antimalarial treatment in pregnant women. Treatment is an artemisinin-based combination therapy (ACT) c given by the oral route for 3 days [1] . The first-line ACT is chosen according to therapeutic efficacy in the area where the patient is living. If the first line ACT is unavailable, contra-indicated or has failed despite being correctly administered, use another ACT. For dosing information, see table below. Page 18 2/ 409